The ribonucleic acid (RNA) markers are purified RNA molecules utilized for investigating gene expressions and performing analysis of coding and non-coding sequences. RNA markers find widespread application in various research activities associated with transcriptomics and gene sequencing. The growing prevalence of genetic diseases and increasing research efforts to develop advanced diagnostic techniques for quicker diagnosis are spurring the demand for RNA markers. The global RNA markers market is estimated to be valued at US$ 347.6 Mn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
One of the major opportunities for the expansion of the RNA markers market is the growing research focus on non-coding sequences analysis. Non-coding RNA sequences, also known as non-coding RNA (ncRNA), do not code for proteins. However, they play vital regulatory roles in gene expression and other cellular processes. With advancement in genomic techniques, researchers are discovering novel functions of ncRNAs in various critical cellular activities and associated diseases. As a result, the demand for specific RNA markers is increasing to carry out extensive analysis of non-coding regions of the human genome. Advanced RNA markers aid in identification and characterization of novel ncRNA species and understanding their roles in health and disease pathology. This growing research in non-coding sequences using specialized RNA markers augurs well for the market growth over the forecast period.
Porter's Analysis
Threat of new entrants: The RNA markers market requires substantial investments in research and development as well as FDA approvals which pose high entry barriers.
Bargaining power of buyers: The bargaining power of buyers is moderate as the market is dominated by a few large players. However, the availability of substitutes provides options to buyers.
Bargaining power of suppliers: The bargaining power of suppliers is low due to the availability of substitutes and lack of differentiation between suppliers.
Threat of new substitutes: Substitutes include DNA markers and other protein based cancer diagnostic methods. However, RNA markers offer advantages in early detection and drug development.
Competitive rivalry: High as the market is growing and dominated by large multinational companies investing heavily in R&D to develop novel products.
SWOT Analysis
Strengths: RNA markers can detect cancer at an early stage. Non-invasive diagnostic technique.
Weaknesses: High development costs. Require specialized equipment and skilled professionals for analysis.
Opportunities: Growing cancer incidence worldwide. Scope for developing combinatorial diagnostic markers.
Threats: Stringent regulatory norms. Reimbursement issues in developing countries. Intense competition.
Key Takeaways
The global ribonucleic acid (RNA) markers market is expected to witness high growth over the forecast period owing to growing incidence of cancers worldwide. The North America region currently dominates the market due to availability of advanced healthcare facilities and high healthcare spending.
Regional analysis related content comprises the Asia Pacific region is expected to grow at the fastest rate during the forecast period. This is attributed to growing geriatric population, rising healthcare expenditure, and increasing awareness regarding early cancer detection in countries such as China and India.
Key players related content comprises Key players operating in the ribonucleic acid (RNA) markers market are Carl Zeiss AG, Hoya Corporation, Canon Inc., Nidek Co., Ltd., Topcon Corporation, Intelligent Retinal Imaging Systems, Inc., Kowa Company Ltd., Optomed Oy (Ltd.), Vision Equipment Inc., Clarity Medical Systems, Inc., Medimaging Integrated Solution Inc., S4OPTIK LLC., Shenzhen Thondar Technology Co., Ltd., CenterVue SpA.
RNA markers market are the collection of RNA transcripts that are synthesized from pre-specified templates for in vitro diagnosis and analysis.
These markers are used for identification and isolation of molecular weight analysis and are not specifically for quantitative analysis of different molecules.
These markers are used to provide a measurable scale of molecular weight which helps provide the fragment size of molecules through gel electrophoresis.RNA markers market is analysed by Data Bridge Market Research, wherein we have accounted for the market to witness a growth rate of 8.40% in the forecasted period of 2020 to 2027.
With the growth witnessed across the entire globe in the expenditure incurred by the major biotechnology market players on enhancing their research & development activities, the consumption rate for different analytical instruments and techniques have witnessed significantly positive impacts for this trend.Get Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-rna-markers-marketMarket Drivers and Restraints:Based on type, the RNA markers market is segmented into prestained markers, unstained markers and specialty markers.On the basis of application, the RNA markers market is segmented as nucleic acid applications and proteomics applications.
Nucleic acid applications are sub-segmented into polymerase chain reaction (PCR), sequencing, northern blotting, southern blotting, molecular cloning and others.
Proteomics applications are sub-segmented into western blotting, gel extraction and others.RNA markers market has also been segmented into academic research institutes, pharmaceutical & biotechnology companies, contract research organizations (CROs) and others on the basis of end user.The major players covered in the RNA Markers Market The major players covered in the RNA markers market report are New England Biolabs, Promega Corporation, Merck KGaA, Takara Bio Inc., Abnova Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN, Bio-Rad Laboratories, Inc., Lonza among other domestic and global players.
RNA markers market are the collection of RNA transcripts that are synthesized from pre-specified templates for in vitro diagnosis and analysis.
These markers are used for identification and isolation of molecular weight analysis and are not specifically for quantitative analysis of different molecules.
These markers are used to provide a measurable scale of molecular weight which helps provide the fragment size of molecules through gel electrophoresis.The improvement in funding and enhancing R activities is not limited to the major market players, this trend is being witnessed across the major authorities and government organizations, this trend in combination with the growth of partnerships being established between the biotechnology companies and pharmaceutical companies are expected to be the major driving factors for RNA markers market.RNA markers market is analysed by Data Bridge Market Research, wherein we have accounted for the market to witness a growth rate of 8.40% in the forecasted period of 2020 to 2027.
With the growth witnessed across the entire globe in the expenditure incurred by the major biotechnology market players on enhancing their research & development activities, the consumption rate for different analytical instruments and techniques have witnessed significantly positive impacts for this trend.Click Here to Get Sample Report of Respiratory polygraph market @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-rna-markers-marketMarket Drivers and Restraints:Based on type, the RNA markers market is segmented into prestained markers, unstained markers and specialty markers.On the basis of application, the RNA markers market is segmented as nucleic acid applications and proteomics applications.
Nucleic acid applications are sub-segmented into polymerase chain reaction (PCR), sequencing, northern blotting, southern blotting, molecular cloning and others.
Proteomics applications are sub-segmented into western blotting, gel extraction and others.RNA markers market has also been segmented into academic research institutes, pharmaceutical & biotechnology companies, contract research organizations (CROs) and others on the basis of end user.The major players covered in the RNA Markers Market The major players covered in the RNA markers market report are New England Biolabs, Promega Corporation, Merck KGaA, Takara Bio Inc., Abnova Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN, Bio-Rad Laboratories, Inc., Lonza among other domestic and global players.
